Log in

OTCMKTS:YEWBYew Bio-Pharm Group Stock Price, Forecast & News

$0.12
0.00 (0.00 %)
(As of 06/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.12
Now: $0.12
$0.12
50-Day Range
$0.08
MA: $0.13
$0.20
52-Week Range
$0.05
Now: $0.12
$0.20
Volume20 shs
Average Volume967 shs
Market Capitalization$5.95 million
P/E Ratio11.51
Dividend YieldN/A
Beta-0.62
Yew Bio-Pharm Group, Inc., through its subsidiaries, grows and sells yew trees in the People's Republic of China. It operates through four segments: Traditional Chinese Medicine (TCM) Raw Materials, Yew Trees, Handicrafts, and Others. The TCM Raw Materials segment engages in the production and sale of raw materials that are used in the manufacture of TCM. It offers yew raw materials, including branches and leaves of yew trees. The Yew Tree segment is involved in growing and selling yew seedlings and mature trees. It cultivates and sells yew seedlings and trees to state-owned enterprises and private businesses for reforestation in the provinces of Heilongjiang and Jilin; and sells potted yew trees to retail customers. The Handicrafts segment manufactures and sells furniture and handicrafts made of yew timber. The Others segment sells yew candles, pine needle extracts, complex taxus cuspidate extract, composite northeast yew extract, and yew essential oil soap. The company also sells wood ear mushroom. Yew Bio-Pharm Group, Inc. was incorporated in 2007 and is based in El Monte, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.06 out of 5 stars


Industry, Sector and Symbol

Industry Agricultural production - crops
Sub-IndustryN/A
Current SymbolOTCMKTS:YEWB
CUSIPN/A
Phone626-401-9588

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$27.88 million
Cash Flow$0.05 per share
Book Value$0.80 per share

Profitability

Net Income$990,000.00

Miscellaneous

Employees46
Market Cap$5.95 million
Next Earnings Date6/10/2020 (Estimated)
OptionableNot Optionable

Receive YEWB News and Ratings via Email

Sign-up to receive the latest news and ratings for YEWB and its competitors with MarketBeat's FREE daily newsletter.

Yew Bio-Pharm Group (OTCMKTS:YEWB) Frequently Asked Questions

How has Yew Bio-Pharm Group's stock been impacted by COVID-19 (Coronavirus)?

Yew Bio-Pharm Group's stock was trading at $0.12 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, YEWB stock has decreased by 4.2% and is now trading at $0.1150. View which stocks have been most impacted by Coronavirus.

When is Yew Bio-Pharm Group's next earnings date?

Yew Bio-Pharm Group is scheduled to release its next quarterly earnings announcement on Wednesday, June 10th 2020. View our earnings forecast for Yew Bio-Pharm Group.

How were Yew Bio-Pharm Group's earnings last quarter?

Yew Bio-Pharm Group Inc (OTCMKTS:YEWB) posted its earnings results on Tuesday, August, 14th. The company reported $0.03 earnings per share (EPS) for the quarter. The business had revenue of $14.82 million for the quarter. Yew Bio-Pharm Group had a net margin of 3.54% and a return on equity of 2.34%. View Yew Bio-Pharm Group's earnings history.

Has Yew Bio-Pharm Group been receiving favorable news coverage?

News headlines about YEWB stock have been trending somewhat positive on Sunday, according to InfoTrie Sentiment. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Yew Bio-Pharm Group earned a news sentiment score of 0.8 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the immediate future. View the latest news aboutYew Bio-Pharm Group.

Who are some of Yew Bio-Pharm Group's key competitors?

Who are Yew Bio-Pharm Group's key executives?

Yew Bio-Pharm Group's management team includes the following people:
  • Mr. Zhiguo Wang, Founder, CEO, Pres & Chairman (Age 57)
  • Madam Guifang Qi, Sec. & Director (Age 57)
  • Mr. Yuxi Xing, Chief Financial Officer (Age 58)
  • Mr. Xingming Han, Gen. Mang. of Harbin Yew Science and Technology Devel. Co Ltd (Age 54)

What is Yew Bio-Pharm Group's stock symbol?

Yew Bio-Pharm Group trades on the OTCMKTS under the ticker symbol "YEWB."

How do I buy shares of Yew Bio-Pharm Group?

Shares of YEWB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Yew Bio-Pharm Group's stock price today?

One share of YEWB stock can currently be purchased for approximately $0.12.

How big of a company is Yew Bio-Pharm Group?

Yew Bio-Pharm Group has a market capitalization of $5.95 million and generates $27.88 million in revenue each year. Yew Bio-Pharm Group employs 46 workers across the globe.

What is Yew Bio-Pharm Group's official website?

The official website for Yew Bio-Pharm Group is www.yewbiopharm.com.

How can I contact Yew Bio-Pharm Group?

Yew Bio-Pharm Group's mailing address is 9460 Telstar Avenue Suite 6, El Monte CA, 91731. The company can be reached via phone at 626-401-9588 or via email at [email protected]

This page was last updated on 6/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.